Schizophrenia is thought to involve a dysfunction of glutamatergic and GABAergic signaling in the prefrontal cortex, but how these systems interact in the disease has been unclear. Now ketamine ...

A study published in Science Signaling on the neural circuitry mediating addiction has made significant strides, particularly in understanding the intricat | Neuroscience ...

Glutamatergic medications showed promise in treating obsessive-compulsive and related disorders (OCRDs), especially obsessive-compulsive disorder (OCD), a systematic review and meta-analysis ...